Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) General Information

Description

Rights to develop, manufacture and commercialize FS001. FS001 is a potential first-in-class ADC with demonstrated preclinical efficacy in multiple solid tumors and a favorable safety profile with a wide therapeutic window in animal studies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Beijing
  • China
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Ipsen
Corporate Office
  • Beijing
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001)‘s full profile, request access.

Request a free trial

Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001)‘s full profile, request access.

Request a free trial

Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) FAQs

  • Where is Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) headquartered?

    Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) is headquartered in Beijing, China.

  • What industry is Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) in?

    Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001)’s primary industry is Buildings and Property.

  • Is Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) a private or public company?

    Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) is a Private company.

  • What is the current valuation of Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001)?

    The current valuation of Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) is .

  • What is Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001)’s current revenue?

    The current revenue for Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) is .

  • Who are Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001)’s investors?

    Foreseen Biotech has invested in Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001).

  • When was Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) acquired?

    Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) was acquired on 11-Jul-2024.

  • Who acquired Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001)?

    Foreseen Biotech (Rights to Develop, Manufacture and Commercialize FS001) was acquired by Ipsen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process